We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Following yesterday’s Personal Consumption Expenditures (PCE) and Wednesday’s Fed meeting and press conference with Fed Chair Kevin Warsh, we quiet down ahead of the final trading session for the week. Despite some mid-week turbulence, we’re trading fairly even with where we were as of mid-day Monday. The Dow is +179 points at this hour, the S&P 500 +12 and the Nasdaq +241 points.
Q2 Employment Costs are out this morning, but unlikely to move the needle in terms of trading sentiment. The headline +0.9% matches the previous quarter and +10 basis points (bps) from expectations. Wages and salaries for civilian workers came in at +3.2%, benefits +3.8%. For state and local government workers, this adjusts to +3.6%.
Q2 Earnings at a Glance: ABBV, XOM & More
AbbVie ((ABBV - Free Report) shares are trading down at this hour, following a beat by a penny on the bottom line to $3.65 per share on revenues of $16.99 billion, +1.07%. The Big Pharma staple has not missed on earnings since 2018. But full-year earnings guidance was pulled lower than current projections, and shares are down -4% presently.
A pair of International Integrated Oil & Gas “supermajors” also reported earnings this morning. ExxonMobil ((XOM - Free Report) posted a negative earnings surprise of -4.35% on lower quarterly oil production, for its second miss in the past four quarters. Chevron ((CVX - Free Report) beat estimates by +4.48%. Both companies blasted past revenues estimates by +21%, though only Chevron is trading higher.
Colgate-Palmolive ((CL - Free Report) outpaced earnings estimates, $0.99 per share versus $0.95, even though higher tariff costs dampened the household products major’s outlook. Revenues were fairly in-line with estimates at $5.36 billion, above the $5.11 billion reported a year ago. Shares are down -1.8% at this hour.
View the Zacks #1 Rank List
Image: Bigstock
Earnings Data Deluge
Following yesterday’s Personal Consumption Expenditures (PCE) and Wednesday’s Fed meeting and press conference with Fed Chair Kevin Warsh, we quiet down ahead of the final trading session for the week. Despite some mid-week turbulence, we’re trading fairly even with where we were as of mid-day Monday. The Dow is +179 points at this hour, the S&P 500 +12 and the Nasdaq +241 points.
Q2 Employment Costs are out this morning, but unlikely to move the needle in terms of trading sentiment. The headline +0.9% matches the previous quarter and +10 basis points (bps) from expectations. Wages and salaries for civilian workers came in at +3.2%, benefits +3.8%. For state and local government workers, this adjusts to +3.6%.
Q2 Earnings at a Glance: ABBV, XOM & More
AbbVie ((ABBV - Free Report) shares are trading down at this hour, following a beat by a penny on the bottom line to $3.65 per share on revenues of $16.99 billion, +1.07%. The Big Pharma staple has not missed on earnings since 2018. But full-year earnings guidance was pulled lower than current projections, and shares are down -4% presently.
A pair of International Integrated Oil & Gas “supermajors” also reported earnings this morning. ExxonMobil ((XOM - Free Report) posted a negative earnings surprise of -4.35% on lower quarterly oil production, for its second miss in the past four quarters. Chevron ((CVX - Free Report) beat estimates by +4.48%. Both companies blasted past revenues estimates by +21%, though only Chevron is trading higher.
Colgate-Palmolive ((CL - Free Report) outpaced earnings estimates, $0.99 per share versus $0.95, even though higher tariff costs dampened the household products major’s outlook. Revenues were fairly in-line with estimates at $5.36 billion, above the $5.11 billion reported a year ago. Shares are down -1.8% at this hour.